These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1712688)

  • 1. Comparative studies of the effects of FK506 and cyclosporin A on passively transferred collagen-induced arthritis in rats.
    Miyahara H; Hotokebuchi T; Arita C; Arai K; Sugioka Y; Takagishi K; Kaibara N
    Clin Immunol Immunopathol; 1991 Aug; 60(2):278-88. PubMed ID: 1712688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by FK506 of established lesions of collagen-induced arthritis in rats.
    Arita C; Hotokebuchi T; Miyahara H; Arai K; Sugioka Y; Kaibara N
    Clin Exp Immunol; 1990 Dec; 82(3):456-61. PubMed ID: 1702374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506--its influence on anti-class 1 MHC alloantibody responses to blood transfusions.
    Propper DJ; Woo J; Thomson AW; Catto GR; Macleod AM
    Transplantation; 1990 Aug; 50(2):267-71. PubMed ID: 1696409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effect of FK506 on collagen-induced arthritis in rats.
    Inamura N; Hashimoto M; Nakahara K; Aoki H; Yamaguchi I; Kohsaka M
    Clin Immunol Immunopathol; 1988 Jan; 46(1):82-90. PubMed ID: 2446810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506, a novel immunosuppressive agent, induces antigen-specific immunotolerance in active Heymann's nephritis and in the autologous phase of Masugi nephritis.
    Okubo Y; Tsukada Y; Maezawa A; Ono K; Yano S; Naruse T
    Clin Exp Immunol; 1990 Dec; 82(3):450-5. PubMed ID: 1702373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin.
    Wicker LS; Boltz RC; Matt V; Nichols EA; Peterson LB; Sigal NH
    Eur J Immunol; 1990 Oct; 20(10):2277-83. PubMed ID: 1700753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum transfer of collagen arthritis to cyclosporin-treated, type II collagen-tolerant rats.
    Kaibara N; Morinaga M; Arita C; Hotokebuchi T; Takagishi K
    Clin Immunol Immunopathol; 1985 May; 35(2):252-60. PubMed ID: 4075591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritic responses mediated by active peripheral suppression.
    Thompson HS; Harper N; Bevan DJ; Staines NA
    Autoimmunity; 1993; 16(3):189-99. PubMed ID: 8003614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion.
    Woo J; Propper DJ; Macleod AM; Thomson AW
    Clin Exp Immunol; 1990 Dec; 82(3):462-8. PubMed ID: 1702375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical.
    Johansson A; Möller E
    Transplantation; 1990 Dec; 50(6):1001-7. PubMed ID: 1701570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription.
    Hultsch T; Albers MW; Schreiber SL; Hohman RJ
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6229-33. PubMed ID: 1712484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of effects of cyclosporins A and G on collagen arthritis in mice.
    Takagishi K; Yamamoto M; Miyahara H; Hotokebuchi T; Kaibara N
    Agents Actions; 1992 Nov; 37(3-4):284-9. PubMed ID: 1295377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of in vivo responses to cyclosporine, FK506, and rapamycin following allogeneic immune challenge.
    Lorber MI; Wilson JH; Harding MW; Gromkowski S; Marks WH
    Transplantation; 1991 Jul; 52(1):167-70. PubMed ID: 1713364
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats.
    Kawashima H; Fujino Y; Mochizuki M
    Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1265-71. PubMed ID: 2458329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CD4 cell is capable of transferring suppression of collagen-induced arthritis.
    Myers LK; Stuart JM; Kang AH
    J Immunol; 1989 Dec; 143(12):3976-80. PubMed ID: 2574207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat.
    Kawashima H; Fujino Y; Mochizuki M
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2500-7. PubMed ID: 1702408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
    Sawada S; Suzuki G; Kawase Y; Takaku F
    J Immunol; 1987 Sep; 139(6):1797-803. PubMed ID: 2442255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an immunosuppressant, FK506, on interleukin 1 alpha production by human macrophages and a macrophage-like cell line, U937.
    Keicho N; Sawada S; Kitamura K; Yotsumoto H; Takaku F
    Cell Immunol; 1991 Feb; 132(2):285-94. PubMed ID: 1703047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclosporin and tacrolimus (FK506) on the antigen-induced mediator release, membrane potential and 86Rb+/K+ and Ca2+ fluxes in the RBL-2H3 cell line.
    Narenjkar J; Assem el-SK; Wan BY; Marsh S; Ezeamuzie CI
    Int Immunopharmacol; 2006 May; 6(5):742-9. PubMed ID: 16546704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclosporin on collagen induced arthritis in mice.
    Takagishi K; Kaibara N; Hotokebuchi T; Arita C; Morinaga M; Arai K
    Ann Rheum Dis; 1986 Apr; 45(4):339-44. PubMed ID: 3754714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.